Cargando…
Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study
In the current post-pandemic era, recipients of an allogeneic hematopoietic stem cell transplant (HCT) deserve special attention. In these vulnerable patients, vaccine effectiveness is reduced by post-transplant immune-suppressive therapy; consequently, severe acute respiratory syndrome coronavirus...
Autores principales: | La Rosa, Corinna, Chiuppesi, Flavia, Park, Yoonsuh, Zhou, Qiao, Yang, Dongyun, Gendzekhadze, Ketevan, Ly, Minh, Li, Jing, Kaltcheva, Teodora, Ortega Francisco, Sandra, Gutierrez, Miguel-Angel, Ali, Haris, Otoukesh, Salman, Amanam, Idoroenyi, Salhotra, Amandeep, Pullarkat, Vinod A., Aldoss, Ibrahim, Rosenzweig, Michael, Aribi, Ahmed M., Stein, Anthony S., Marcucci, Guido, Dadwal, Sanjeet Singh, Nakamura, Ryotaro, Forman, Stephen J., Al Malki, Monzr M., Diamond, Don J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020189/ https://www.ncbi.nlm.nih.gov/pubmed/36936918 http://dx.doi.org/10.3389/fimmu.2023.1114131 |
Ejemplares similares
-
Tacrolimus initial steady state level in post-transplant cyclophosphamide based GvHD prophylaxis regimens
por: Yao, Janny M., et al.
Publicado: (2022) -
Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Ali, Haris, et al.
Publicado: (2021) -
The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study
por: Ngo, Dat, et al.
Publicado: (2023) -
Putative Protective Role of Sars-Cov-2-Specific T Cells in an HCT Patient Transplanted during Active COVID19 Infection
por: Pourhassan, Hoda, et al.
Publicado: (2022) -
Use of monoclonal antibody therapy in hematologic patients with mild‐to‐moderate COVID‐19: A retrospective single‐center experience
por: Amanam, Idoroenyi, et al.
Publicado: (2023)